by Dr Roger Watson,Daily Sceptic:

No sooner had the COVID-19 ‘pandemic’ subsided than, in 2022,the monkeypox ‘pandemic’ came into view, global health officials waving graphs, emergency declarations and, inevitably, vaccine contracts. The parallels with early 2020 were so obvious that they hardly needed repeating: ‘outbreaks’, ‘containment’,isolation periods,R values,variants(in breaking news, the WHO has reported anew recombinant variant of monkeypox: one case in the UK and one in India, but fears there may be more unreported cases, naturally), and the sense that the public must be coached, firmly, into behaving as if a handful of cases were the opening credits of the next apocalypse.

TRUTH LIVES on athttps://sgtreport.tv/

An outbreak in search of some numbers

Early on, the UK was ‘ramping up efforts’, people were advised to isolate for 21 days (the maximum incubation period), and Belgium reportedly flirted with mandatory isolation. TheNHS advice was comparatively low-key, and even some US voices suggested this wasnot the ‘next Covid’. But the calm did not survive long.

The problem for the doom-mongers was that monkeypox refused to cooperate.It did not spread like wildfireand it did not fill hospitals. Reports from the WHO spoke of suspected cases and deaths in ways that were less than transparent: more deaths than confirmed cases were reportedin one summary.

Monkeypox has long beenendemic in parts of West and Central Africa, and outside Africa the 2022 outbreak was heavily concentrated in a specific high-risk group:men who have sex with men. Public health agencies insisted, often with convoluted, euphemistic prose, that ‘anyone’ could be at risk, while simultaneously describing transmission driven by close physical contact, particularly sexual contact. The effort toavoid ‘stigma’became an excuse to avoid specificity, and specificity is precisely what you need when you are giving risk information. If the disease is overwhelmingly concentrated in one behaviour-linked network, pretending otherwise does not reduce stigma; it reduces clarity.

Micromanaging private life did not start with monkeypox, but monkeypox shows how quickly it returns once an ‘emergency’ is declared. For example, theCDC’s “safer sex” adviceissued guidance to “masturbate at least six feet away from your partner”.

Once you have declared an emergency, you need a product. In this story the products were chieflysmallpox-derived vaccines: JYNNEOS (also known as Imvanex/Imvamune, sometimes described as MVA‑BN), LC16 and ACAM2000. The CDC itself noted that clinicalefficacy and effectiveness data for monkeypox disease were limited, yet orders rolled in anyway, including large US purchases.Children were even floated as targetsafter a tiny number of paediatric cases. Once you have warehouses of doses, you need arms.

As with Covid, the numbers reported for monkeypox vaccine effectiveness depended on the public not understanding basic arithmetic. Figures like “85% effective” or estimates that JYNNEOS is “66 to 89% effective after two doses” were reported.These are almost always relative risk reductions (RRR): how much less likely a vaccinated person is to become infected compared with an unvaccinated person in the same setting.

Source: SGT Report